Y-Intercept (HK)’s Acumen Pharmaceuticals ABOS Stock Holding History

Y-Intercept (HK)’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.9K	Buy	+29,540	New	+$73K	﹤0.01%	1615
2025 Q3	–	Sell	-250,848	Closed	-$291K	–	1514
2025 Q2	$291K	Buy	+250,848	New	+$270K	0.01%	1368
2024 Q2	–	Sell	-37,191	Closed	-$151K	–	1328
2024 Q1	$151K	Buy	37,191 +17,843	+92%	+$67.3K	0.01%	1203
2023 Q4	$74.3K	Buy	+19,348	New	+$57.4K	0.01%	1133

Other funds holding ABOS

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Clune & Associates Chicago, Illinois $661M AUM 21.51% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s ABOS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 29,540 shares worth $78.9K. The stake represents ﹤0.01% of the portfolio and ranks #1615 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ABOS as recently as Q2 2025.

Y-Intercept (HK) first reported a position in ABOS in Q4 2023 and has held it in 4 quarters since. The position peaked at $291K in Q2 2025. 4 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

Y-Intercept (HK) held 29,540 shares of Acumen Pharmaceuticals worth $78.9K as of Q2 2026.
Acumen Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1615 holding.
Y-Intercept (HK) first reported a position in Acumen Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
Y-Intercept (HK)'s Acumen Pharmaceuticals position peaked at $291K in Q2 2025.
4 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.